missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human LIMD2 (aa 105-126) Control Fragment Recombinant Protein
Recombinant Protein
Supplier: Invitrogen™ RP107202
Description
Highest antigen sequence indentity to the following orthologs: Mouse (95%), Rat (95%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-66538 (PA5-66538. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Acts as an activator of the protein-kinase ILK, thereby regulating cell motility (PubMed:24590809). [UniProt]Specifications
| Q9BT23 | |
| Blocking Assay, Control | |
| 80774 | |
| 100 μL | |
| 0610025L06Rik; AI413966; LIM domain containing 2; LIM domain-containing protein 2; LIMD2; RGD1309967; SB143; testicular tissue protein Li 106 | |
| LIMD2 | |
| Human | |
| His-ABP-tag | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| ≥5.0 mg/mL | |
| 1 M urea, PBS with no preservative; pH 7.4 | |
| Human LIMD2 (aa 105-126) Control Fragment | |
| RUO | |
| LIMD2 | |
| Unconjugated | |
| Recombinant | |
| GFGRKQHKELWAHKEVDPGTKT | |
| E. coli | |
| >80% by SDS-PAGE and Coomassie blue staining |